LTGO Latigo Biotherapeutics, Inc.
$22.15▲ +2.83%
Healthcare
Other
After hours
$22.15▲ +0.00%
Sep 11, 4:43 PM ET
Volume 178.7K
Avg Volume (10D) 220.8K
Key Metrics & Fundamentals
Market Cap
$1.47B
P/E Ratio
–
Div Yield
–%
52W Range
17.22 - 25.93
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
54.7
Free Cash Flow
-$21.39M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’
TipRanks · Sep 8, 2026 6:01 PM
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Sep 3, 2026 8:05 PM
Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public
24/7 Wall St. · Aug 13, 2026 1:35 PM
Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued
Simply Wall St. · Aug 10, 2026 3:19 AM
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
GlobeNewswire · Aug 7, 2026 12:03 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LTGO's money flow as a full page
Social Sentiment
No Reddit posts found for LTGO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.